Graphdiyne (GDY), a two-dimensional artificial-synthesis carbon material, has aroused tremendous interest because of its unique physical properties. The very high activity affords the possibility to chemically dope GDY with metal atoms or lightweight elements such as hydrogen and halogen and so on. Chemical doping has been confirmed to be an effective method to lead to various GDY derivatives with useful physical properties. Thus, this review is intended to provide an overview of the electronic, optical, and magnetic properties of pristine GDY and its derivatives reported from theories to experiments. Because of the importance of pristine GDY and its derivatives in real applications, we also summarize the main physical applications of GDY and its derivatives reported in recent years in this review. We believe that the review will be valuable to all those interested in GDY.
We have observed a large exchange bias field HE ≈ 2460 Oe and a large coercive field HC ≈ 6200 Oe at T = 2 K for Co/CoO core-shell nanoparticles (~4 nm diameter Co metal core and CoO shell with ~1 nm thickness) embedded in a non-magnetic MgO matrix. Our results are in sharp contrast to the small exchange bias and coercive field in the case of a non-magnetic Al2O3 or C matrix materials reported in previous studies. Using soft X-ray magnetic circular dichroism at the Co-L2,3 edge, we have observed a ferromagnetic signal originating from the antiferromagnetic CoO shell. This gives direct evidence for the existence of rotatable interfacial uncompensated Co spins in the nominally antiferromagnetic CoO shell, thus supporting the uncompensated spin model as a microscopic description of the exchange bias mechanism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.